Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
A new Dartmouth study opens new avenues for understanding—and potentially manipulating—how cells decide to live or die. Scientists have long known that mitochondria—a cell's tiny power plants—pull ...
The new BMW iX3, unveiled at CES 2026, introduces a major leap in electric-car technology with AI-powered Alexa+ voice ...
News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...
If we rewind time and go back to Episode 2 of Mayor of Kingstown Season 1, the episode circles back to an event first seen in ...
BOE and its subsidiary make a strong presence at the show, bringing over 60 cutting-edge display technologies and IoT ...
If you get stranded during winter. it can be life threatening. What to include in an emergency kit to help you survive.
Renault has decided to equip the Twingo with extensive features, while keeping power and range limited.
Ford says it is contributing more to Red Bull’s new Formula 1 engines than originally discussed, which is linked to the Blue ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest forms of blood cancer, T-cell acute lymphoblastic leukaemia. By precisely ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果